Novavax’s Covid-19 vaccine gets approval in South Korea for adolescents
The approval was based on findings from a paediatric expansion of the Phase III PREVENT-19 clinical trial of Nuvaxovid.
South Korea
Latest in
South Korea
Samsung Biologics and GreenLight conclude Covid-19 vaccine engineering run
The clinical trial of GreenLight’s Covid-19 booster vaccine is anticipated to commence this year.
Samsung Biologics acquires Samsung Bioepis joint venture for $2.3bn
The takeover will offer Samsung Biologics with biosimilar development expertise and future performance in new drug development.
RedHill and Kukbo sign oral Covid-19 therapy licence deal in South Korea
Under the deal, Kukbo will gain exclusive rights to market opaganib for Covid-19 in the region.
Samsung Biologics to acquire Biogen’s stake in Samsung Bioepis for $2.3bn
Biogen is eligible to receive up to $50m from Samsung Biologics on meeting some commercial milestones.
South Korea grants approval to Novavax Covid-19 vaccine
SK bioscience will handle the manufacturing and commercialisation of the vaccine in South Korea.
Hyundai Bioscience finds combination therapy effective against Covid-19
In a study, oral CP-COV03 plus dexamethasone was found to be 2.1 times effective than dexamethasone alone.
Enzychem and Cadila collaborate to produce Covid-19 vaccine in Korea
The partnership between Enzychem and Cadila is expected to manufacture 80 million or more doses of the vaccine next year.